View Article

Abstract

The aim of the study was to determine the antifungal activity of latex obtained from the A. scholaris and E. milii. A comparative study was conducted to assess the antifungal efficacy of A. scholaris and E. milii Latex against Candida albicans. Zone of inhibition of plant extracts with respect to five concentrations viz. 0.06µg/ml, 0.12µg/ml, 0.25 µg/ml,0.5 µg/ml, and 1µg/ml have been done. Prior determining the antifungal activity phytochemical screening of plant latex are done. Phytochemical screening of plant extracts showed the presence of alkaloids, saponins, and carbohydrates. A. scholaris and E. milii exhibit promising potential as alternative treatment for onychomycosis. E. milii shows its antifungal activity at concentrations of 0.06µg/ml, 0.12µg/ml, 0.25µg/ml, 0.5µg/ml, and 1 µg/ml with the zone of inhibition of 11mm, 12mm, 15mm, and 13mm respectively and no zone of inhibition was obtained at 0.25µg/ml. A. scholaris shows its antifungal activity at concentrations of 0.06µg/ml, 0.12µg/ml, 0.25µg/ml, 0.5µg/ml, and 1µg/ml with a zone of inhibition of 25mm, 16mm, and 15mm respectively, while no zone of inhibition was obtained at 0.12µg/ml and 1µg/ml. The result demonstrates the antifungal potential of selected plant latexes from E. milii and A. scholaris. The A. scholaris was found to be more effective for its antifungal activity than E. milii.

Keywords

Alstonia scholaris; Euphorbia milii; Candida albicans; Esherichia coli; Antifungal activity; Anti-bacterial activity

Introduction

India is a vast country with more than a billion people and spread over an area of 3.3 thousand million sq. kilometers. Located in the tropics, receiving a heavy annual monsoon makes climatic conditions favorable for fungi to grow in the major part of the country. [1] Fungal infections, otherwise known as mycosis, are diseases caused by fungus. Fungal infections are most common on skin or nails. Onychomycosis is a nail infection by fungus, causing discoloration and thickening of the affected nail plate. The major causative agents of onychomycosis are dermatophytes. However, new research has revealed that non-dermatophyte molds are also a causative agent and are more prevalent, especially in warmer climates. Microscopy and fungal culture are the earlier diagnosing methods, and histology and PCR are done for more accurate diagnosis. Generally, involvement of the nail plate by Candida albicans is rare. Around 80%-90% of all nail infections are caused by dermatophytes, and studies in the UK found that Candida species (11%-15%) are also isolated from toenails. [2] The disease is reported to have an overall prevalence of 2% to 13%, but the prevalence is much higher in certain populations, such as older people and those with immunosuppressive conditions. [3] Around 0.5% of people under 18 were affected by this fungal nail infection. [3] Oral antifungals, topicals, and devices are the various treatment options. Oral antifungals such as terbinafine, itraconazole, and fluconazole have higher cure rates and shorter treatment periods than topical agents but have adverse side effects and drug interaction. New antifungals such as fosravuconazole are being evaluated. Topical treatments have serious side effects, but lower cure rates and much longer treatment regimens. New topical formulations are being evaluated in such a way as faster-acting alternatives to the currently available topical treatments. Laser devices are used to improve the cosmetic appearance of the nail, but their effectiveness for onychomycosis has yet to be sufficiently proven.

Factors such as the growth of toenails, nail keratin thickness preventing the penetration of topicals and systemic drugs, and survival of fungi in the surrounding environment such as footwear for longer periods resulting in limited efficacy of current treatment. [4] Certain of these factors make the patient ineligible for oral antifungals and also the side effects associated with oral antifungals result in patient non-adherence and failure of the treatment.

In the 21st century, herbal medicine has been considered a promising future medicine for the management of health care. Overall, nowadays, the demand for plant-based medicines, health products, food supplements, and cosmetics has increased in both developing and developed countries, because natural products are nontoxic, have fewer side effects, and are easily available at affordable prices. [5] Phytochemical constituents present in medicinal plants are essential for the development of new drugs. For centuries, people have turned to natural remedies to cure self-limiting diseases such as colds, allergies, toothaches, etc. However the use of herbal medicines has been declined in the mid-20th century because they were not economically profitable as the newer synthetic drugs. [6] Later on, the toxic effects of conventional medicine resulted in the promotion of “natural health”, where there occur a shift in the universal trend from synthetic to herbal medicines. Undoubtedly the demand for plant-derived products has increased worldwide. Many species have been used in traditional and complementary medicine for the treatment of various microbial diseases such as fungus-causing onychomycosis. The utilization of Euphorbia milii and Alstonia scholaris has shown numerous traditional evidence. One of the largest and oldest plant families in the world, comprising approximately 300 genera and 8000 species is Euphorbiacea. Euphorbia milii is frequently used in folk medicine to treat warts, cancer, hepatitis, and trichiasis. [7] In the world around 60 species of Alstonia are present and in India around 6 species are found, where some of the species have medicinal importance. [8] It belongs to the Apocynaceae family. In AYUSH and non-codified drug system, the various parts of Alstonia scholaris are used for the treatment of malaria, jaundice, gastrointestinal troubles, cancer, etc. [8]

MATERIALS AND METHODS

Procurement of the Plant material

A. scholaris were collected from the nearby temple Sree Mariyamman Kovil, and E. milii were collected from Wayanad planters and prepared the herbarium. The plants were authenticated by a Botanist. Follicles of A. scholaris were collected and the follicles were cut with sharp blades and compressed to collect milky white latex in a container. Latex is stored at 0-40C in the refrigerator until used. Latex from the E. milii has collected aseptically. After a longitudinal cut in the plant stem, the latex was collected into glass tubes that were sealed, wrapped in aluminium foil, and evaporated to dryness. Dried samples of latex were stored in tightly closed glass vials that were kept protected from light in the refrigerator (4–6°C) until further use. Collected latex of E. milii and A. scholaris diluted with DMSO with concentrations 0.06, 0.12, 0.25, 0.50& 1 mg/L for antifungal activity.

Phytochemical screening

Different chemical tests such as Wagner’s test, Molisch’s test, ferric chloride test, frothing test and Ninhydrin test were conducted to detect the presence of Alkaloids, carbohydrates, phenolic compounds, saponins, and amino acids in A. scholaris and E. milli.

Antifungal study: Agar well diffusion method

For the culture of C. albicans, Potato Dextrose Agar (PDA) media was used. 20 ml of sterile culture media were poured into Petri plates. Then, 1 ml of inoculum suspension of C. albicans was spread over the medium. A well of 6 mm was made using a sterile cork borer. Then, 100 microlitres of extract were added. The Petri plates were incubated for 48 hours at 37°C. The zone of inhibition of each Petri plate was measured. The standard used in this study was Amphotericin B (0.25 mg/L as MIC). The Activity Index (AI) and Percentage Activity (PA) were determined by using the following Equations,

Activity Index= Zone of inhibition of test / Zone of inhibition of control

Percentage Activity= Activity Index 100

RESULT

Alstonia scholaris and Euphorbia milii were collected and authenticated. Latex from both plants were collected stored. Dilutions were made with concentrations of 0.06, 0.12, 0.25, 0.50 & 1 mg/L for antifungal activity.

QUALITATIVE PHYTOCHEMICAL SCREENING

Qualitative chemical tests were carried out in both the latex obtained from Alstonia scholaris and Euphorbia milii. The result of the chemical test for latex obtained was tabulated in the following table (Table:1).


 

SN

TESTS

RESULT

A. scholaris

E.milii

1

Test for alkaloids

+++

+++

2

Test for carbohydrates

+++

+++

3

Test for phenolic compound

++

+

4

Test for saponins

++

++

5

Test for amino acids

-

-


Table 1: Qualitative chemical test for Alstonia scholaris and Euphorbia milii

The latex obtained from Alstonia scholaris and Euphorbia milii were subjected to preliminary phytochemical analysis, revealing the presence of various chemical constituents such as alkaloids, phenolic compounds, carbohydrates, saponins, etc. The phytochemical screening confirms the presence of anti-fungicidal components, with alkaloids potentially contributing to antimicrobial activity.

ANTIFUNGAL ACTIVITY

Anti-fungal activity of latex obtained from Alstonia scholaris and Euphorbia milii has been carried out and tabulated in table: 2. Zone of inhibitions of latex of Alstonia scholaris of three concentrations such as 0.06 µg/ml, 0.25 µg/ml, and 0.5 µg/ml has done and the diameters observed were 25mm, 16mm, 15mm respectively. Zone of inhibitions of latex obtained from Euphorbia milii of four concentrations such as 0.06 µg/ml, 0.12 µg/ml, 0.5 µg/ml, and 1 µg/ml has been done and the diameters observed were 11mm, 12mm, 15mm, and 13mm respectively (Figure: 1). The standard drug Amphotericin B was taken in 50 mg/ml concentration and diameter was found to be 20mm. The zone of inhibition of Alstonia scholaris and Euphorbia milii were compared to that of standard drug Amphotericin B and were found to be comparatively less.


Table 2: Anti-fungal activity of Alstonia scholaris and Euphorbia milii latex

DILUTION (mg/L)

A. scholaris

E. milii

ZOI (mm)

Activity Index

Percentage Activity

ZOI (mm)

Activity Index

Percentage Activity

0.06

25

1.25

125

11

0.55

55

0.12

0

0

0

12

0.6

60

0.25

16

0.8

80

0

0

0

0.5

15

0.75

75

15

0.75

75

1

0

0

0

13

0.65

65

Undiluted latex

0

0

0

0

0

0

Standard

20

1

100

20

1

100


       
            Figure 1.jpg
       

Figure 1: Zone of inhibition of C. albicans (A)different concentrations of Alstonia scholaris and Euphorbia milii, (B) by combination of latex of Alstonia scholaris and Euphorbia milii, (C) std. solution of Amphotericin B

       
            Figure 2.png
       

Figure 2: (A) ZOI of Alstonia scholaris and Euphorbia milii latex, (B) Activity Index of Alstonia scholaris and Euphorbia milii latex, (C) Percentage Activity of Alstonia scholaris and Euphorbia milii latex

COMPARATIVE ANALYSIS of

Alstonia scholaris and Euphorbia milii

Zone of inhibitions of the latex of Alstonia scholaris of two concentrations 0.06 µg/ml and 0.5 µg/ml and the diameters observed were 25mm and 15mm respectively (Table: 3). Zone of inhibitions of latex obtained from Euphorbia milii of two concentrations like 0.06 µg/ml and 0.5 µg/ml has been done and the diameters observed were 11mm and 15mm respectively. The standard drug Amphotericin B was taken in 50 mg/ml concentration and the diameter was found to be 20mm. The zone of inhibition of Alstonia scholaris and Euphorbia milii were compared to that of the Amphotericin B and were found to be comparatively less (Figure: 3).


Table 3: Comparative analysis of Alstonia scholaris and Euphorbia milii

DILUTION (mg/L)

A. scholaris

E. milii

ZOI (mm)

Activity Index

Percentage Activity %

ZOI (mm)

Activity Index

Percentage Activity %

0.06

25

1.25

125

11

0.55

55

0.5

15

0.75

75

15

0.75

75

Combination of both latex

0

0

0

0

0

0

Standard

20

1

100

20

1

100


       
            Comparative analysis ofAlstonia scholaris and Euphorbia milii.png
       

Figure 3: Comparative analysis of Alstonia scholaris and Euphorbia milii

DISCUSSION 

Candida albicans, a prevalent opportunistic fungal pathogen, plays a crucial role in causing various infections, particularly in immunocompromised individuals. Its ability to switch between different morphological forms and its arsenal of virulence factors make it a formidable adversary in the clinical setting. Moreover, the rise in antifungal resistance poses a serious challenge in the management of these infections. Therefore, understanding the biology and pathogenicity of Candida albicans, along with the mechanisms of action and limitations of current antifungal therapies, is essential to develop effective strategies to combat this medically significant fungal pathogen. Amphotericin B is effective against the majority of the Candida species, including Candida albicans, which was chosen as the control in the study and showed a MIC value of 0.25 mg/L. This study was aimed at determining the antifungal activity of the latex obtained from Euphorbia milii and Alstonia scholaris against Candida albicans by the agar well diffusion method. Different phytochemicals with biological activity can be found in a variety of herbs and herbal extracts, offering therapeutic value. The latex obtained from Alstonia scholaris and Euphorbia milii was subjected to preliminary phytochemical analysis, revealing the presence of chemical constituents such as alkaloids, phenolic compounds, carbohydrates, saponins, etc. This was in accordance with Deepak Ganjewala [9] and Amal Z Hassan, [10] were they also reported the same phytochemical profile for the both plants.

The agar well diffusion assay is a standard method widely used for the rapid screening of natural products for antimicrobial activity. Plant latexes were screened using this very convenient assay method. The results indicate that caution is needed, since the latexes may have different diffusion rates on the agar plate, and this may contribute to variations in the size of the inhibitory zones, leading to erroneous conclusions regarding their antifungal activity. Euphorbia milii shows its antifungal activity at concentrations of 0.06 mg/L, 0.12 mg/L, 0.25, 0.5mg/L, and 1mg/L with zone of inhibition of 11mm, 12mm 15mm, and 13mm respectively, while Alstonia scholaris shows its antifungal activity at concentrations of 0.06 mg/L, 0.12 mg/L, 0.25 mg/L, 0.5 mg/L, and 1 mg/L with a zone of inhibition of 25mm, 16mm, and 15mm respectively. Fungal activity is considered a desirable quality for antifungal agents since it can eliminate the fungus from tissues. The phytochemical screening confirms the presence of phenolic compounds which exhibit anti-fungal activity. [11] In the comparative study of both plants, it was found that Euphorbia milii shows its antifungal activity at a concentration of 0.5 µg/ml with a zone of inhibition of 15mm, while Alstonia scholaris shows its antifungal activity at a concentration of 0.06 µg/ml with a zone of inhibition of 25mm. The Alstonia scholaris was found to be more effective for its antifungal activity than Euphorbia milii. Amphotericin B and Ampicillin are known to be very effective against human pathogenic fungi and bacteria and despite their severe side effects, may require prolonged use. It is encouraging to note that both the latex obtained from Euphorbia milii and Alstonia scholaris in the study were fungicidal at low concentrations. Until now not much information was available about the mode of action of natural products that inhibit Candida growth, hence further studies focused on the method of action could be beneficial to understand the mechanism of both drugs on antifungal activity.

CONCLUSION

In conclusion, the comparative study of latexes obtained from Euphorbia milii and Alstonia scholaris for the management of onychomycosis has provided valuable insights into the potential of these natural sources as alternative treatments for fungal nail infections. Through the investigation, it was found that both Euphorbia milii and Alstonia scholaris possess antifungal properties, which can be attributed to the presence of bioactive compounds within their latex. These compounds have demonstrated inhibitory effects on the growth of fungi responsible for onychomycosis, making them potential candidates for the development of antifungal medications. However, further research is necessary to determine the specific mechanisms of action and efficacy of these natural latex extracts against onychomycosis. Additionally, studies on the safety, dosage, and potential side effects of these treatments should be conducted to ensure their suitability for clinical applications. Nonetheless, this comparative study serves as a foundation for future investigations and highlights the importance of exploring natural alternatives for the management of onychomycosis. The findings contribute to the growing body of knowledge on natural products as potential sources of novel antifungal agents, offering potential benefits for patients suffering from fungal nail infections.

REFERENCES

  1. Priyamvada H, Singh RK, Akila M, Ravikrishna R, Verma RS, Gunthe SS. Seasonal variation of the dominant allergenic fungal aerosols–One year study from southern Indian region. Scientific reports. 2017;7(1):11171.
  2. Eldridge ML, Chambers CJ, Sharon VR, Thompson III GR. Fungal infections of the skin and nail: new treatment options. Expert review of anti-infective therapy. 2014;12(11):1389-405.
  3. Levy LA. Epidemiology of onychomycosis in special-risk populations. Journal of the American Podiatric Medical Association. 1997;87(12):546-50.
  4. Gupta AK, Simkovich AJ, Hall DC. The March Against Onychomycosis: A Systematic Review of the Sanitization Methods for Shoes, Socks, and Textiles. Journal of the American Podiatric Medical Association. 2022;112(4).
  5. David B, Wolfender JL, Dias DA. The pharmaceutical industry and natural products: historical status and new trends. Phytochemistry Reviews. 2015;14: 299-315.
  6. Pal SK, Shukla Y. Herbal medicine: current status and the future. Asian pacific journal of cancer prevention. 2003; 4(4):281-8.
  7. Chohan TA, Sarfraz M, Rehman K, Muhammad T, Ghori MU, Khan KM, Afzal I, Akash MS, Malik A, Chohan TA. Phytochemical profiling, antioxidant and antiproliferation potential of Euphorbia milii var.: Experimental analysis and in-silico validation. Saudi Journal of Biological Sciences. 2020; 27(11):3025-34.
  8. Khyade MS, Kasote DM, Vaikos NP. Alstonia scholaris (L.) R. Br. and Alstonia macrophylla Wall. ex G. Don: A comparative review on traditional uses, phytochemistry and pharmacology. Journal of ethnopharmacology. 2014;153(1):1-8.
  9. Ganjewala D, Gupta AK. Study on Phytochemical Composition, Antibacterial and Antioxidant Properties of Different Parts of Alstonia scholaris Linn. Advanced pharmaceutical bulletin. 2013; 3(2):379.
  10. Hassan AZ, Sweelam HT, Shaker KH, Zohair MM, Ashour WE, Abd-Alla HI. Phytochemical Analysis and Antimicrobial Activity of Euphorbia milii. Egyptian Journal of Chemistry. 2023; 66(13):461-73.
  11. Teodoro GR, Ellepola K, Seneviratne CJ, Koga-Ito CY. Potential use of phenolic acids as anti-Candida agents: A review. Frontiers in microbiology. 2015 ;5 (6):1420.

Reference

  1. Priyamvada H, Singh RK, Akila M, Ravikrishna R, Verma RS, Gunthe SS. Seasonal variation of the dominant allergenic fungal aerosols–One year study from southern Indian region. Scientific reports. 2017;7(1):11171.
  2. Eldridge ML, Chambers CJ, Sharon VR, Thompson III GR. Fungal infections of the skin and nail: new treatment options. Expert review of anti-infective therapy. 2014;12(11):1389-405.
  3. Levy LA. Epidemiology of onychomycosis in special-risk populations. Journal of the American Podiatric Medical Association. 1997;87(12):546-50.
  4. Gupta AK, Simkovich AJ, Hall DC. The March Against Onychomycosis: A Systematic Review of the Sanitization Methods for Shoes, Socks, and Textiles. Journal of the American Podiatric Medical Association. 2022;112(4).
  5. David B, Wolfender JL, Dias DA. The pharmaceutical industry and natural products: historical status and new trends. Phytochemistry Reviews. 2015;14: 299-315.
  6. Pal SK, Shukla Y. Herbal medicine: current status and the future. Asian pacific journal of cancer prevention. 2003; 4(4):281-8.
  7. Chohan TA, Sarfraz M, Rehman K, Muhammad T, Ghori MU, Khan KM, Afzal I, Akash MS, Malik A, Chohan TA. Phytochemical profiling, antioxidant and antiproliferation potential of Euphorbia milii var.: Experimental analysis and in-silico validation. Saudi Journal of Biological Sciences. 2020; 27(11):3025-34.
  8. Khyade MS, Kasote DM, Vaikos NP. Alstonia scholaris (L.) R. Br. and Alstonia macrophylla Wall. ex G. Don: A comparative review on traditional uses, phytochemistry and pharmacology. Journal of ethnopharmacology. 2014;153(1):1-8.
  9. Ganjewala D, Gupta AK. Study on Phytochemical Composition, Antibacterial and Antioxidant Properties of Different Parts of Alstonia scholaris Linn. Advanced pharmaceutical bulletin. 2013; 3(2):379.
  10. Hassan AZ, Sweelam HT, Shaker KH, Zohair MM, Ashour WE, Abd-Alla HI. Phytochemical Analysis and Antimicrobial Activity of Euphorbia milii. Egyptian Journal of Chemistry. 2023; 66(13):461-73.
  11. Teodoro GR, Ellepola K, Seneviratne CJ, Koga-Ito CY. Potential use of phenolic acids as anti-Candida agents: A review. Frontiers in microbiology. 2015 ;5 (6):1420.

Photo
Dr. Fasalu Rahiman OM
Corresponding author

Dr. Moopen's college of pharmacy, Naseera Nagar, Meppadi, Wayanad, Kerala, India-673577

Photo
Jeeva James
Co-author

Dr. Moopen's college of pharmacy, Naseera Nagar, Meppadi, Wayanad, Kerala, India-673577

Photo
Dr. Lal Prasanth M. L.
Co-author

Dr. Moopen's college of pharmacy, Naseera Nagar, Meppadi, Wayanad, Kerala, India-673577

Photo
Farsana P
Co-author

Dr. Moopen's college of pharmacy, Naseera Nagar, Meppadi, Wayanad, Kerala, India-673577

Photo
Liyana Rasheed
Co-author

Dr. Moopen's college of pharmacy, Naseera Nagar, Meppadi, Wayanad, Kerala, India-673577

Photo
Mubashira P. C.
Co-author

Dr. Moopen's college of pharmacy, Naseera Nagar, Meppadi, Wayanad, Kerala, India-673577

Jeeva James, Fasalu Rahiman OM*, Farsana P, Liyana Rasheed, Mubashira P. C., Lal Prasanth M. L., A Comparative Study on Euphorbia Milii and Alstonia Scholaris Latex for The Management of Onychomycosis, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 1, 789-795. https://doi.org/10.5281/zenodo.14631753

More related articles
A Review on Nanotechnology in Drug Delivery System...
Satpute pratibha , Pawar Harshada, Rode Nikita, Nalage Nikita, ...
Pharmacogenomics: Personalized Medicine in Pain Ma...
Farhan Khan, Kasim Bhuriwale, Adil Shah Bad Shah, Dr. Shivshanka...
A Comprehensive Review On History, Pathogenesis, A...
Adithi P., Monika N., , Nasiba N. K., , Nidhishree S., , Nikshep ...
Benefits Of Computer System Validation In Pharmaceutical Industry...
Meenal Katre, Diksha Ghyar, Saurabh Raghute, Chandak Kamala, Umekar Milind , ...
Structure Biosynthesis And Examination Of Bioactive Small Molecule...
Pravin D. Chand, A. S. sanap, Prachi P. Udapurkar, ...
Innovations In Oral Drug Administration: Exploring Gastro Retentive Raft Forming...
VIGNESH . R, Kamaleshwari B., Kaviya G., Kovarthanan M., Mohan Raj U., ...
Related Articles
Formulation Development And Evaluation Of Gastroretentive Floating Tablets Of Cl...
Kajal A Choursiya, Sachin M Nikam, Khanderao R Jadhav, Rishikesh S Bachhav, ...
Natural Polymers as Excipient in Formulation of Novel Drug Delivery System...
Yukti Mahajan, Dev Raj Sharma, Pravin Kumar, Mahender Singh Ashawat, ...
Formulation And Development of Novel Microemulsion Of Acyclovir...
Shweta Kumari, Neeraj Soni, Neha Rathore, Shruti Rathore, ...
Microbes Drug Delivery System A Comprehensive Review...
Archana chauhan , Pradeep Yadav , Kakli Rai, Jitendra Jena, Jitendra K. Rai, ...
A Review on Nanotechnology in Drug Delivery System...
Satpute pratibha , Pawar Harshada, Rode Nikita, Nalage Nikita, ...
More related articles
A Review on Nanotechnology in Drug Delivery System...
Satpute pratibha , Pawar Harshada, Rode Nikita, Nalage Nikita, ...
Pharmacogenomics: Personalized Medicine in Pain Management ...
Farhan Khan, Kasim Bhuriwale, Adil Shah Bad Shah, Dr. Shivshankar Mhaske, Satish Lodhe, ...
A Comprehensive Review On History, Pathogenesis, And Treatment Innovations For M...
Adithi P., Monika N., , Nasiba N. K., , Nidhishree S., , Nikshep N. S., , P. Jeevitha, ...
A Review on Nanotechnology in Drug Delivery System...
Satpute pratibha , Pawar Harshada, Rode Nikita, Nalage Nikita, ...
Pharmacogenomics: Personalized Medicine in Pain Management ...
Farhan Khan, Kasim Bhuriwale, Adil Shah Bad Shah, Dr. Shivshankar Mhaske, Satish Lodhe, ...
A Comprehensive Review On History, Pathogenesis, And Treatment Innovations For M...
Adithi P., Monika N., , Nasiba N. K., , Nidhishree S., , Nikshep N. S., , P. Jeevitha, ...